Federal Circuit Reinstates Jury Verdict Finding Claims of Biogen’s MS Drug Were AnticipatedBy: Steve Brachmannon September 30, 2020 at 1:33 pm Publication: IPWatchdog.com | Patents & Patent Law

On Monday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Biogen MA, Inc. v. EMD Serono, Inc., reversing the U.S. District Court for the District of New Jersey’s judgment as a matter of law (JMOL) for Biogen. The New Jersey court had found no anticipation o  Read More>>

Categories   Courts, District Courts, Federal Circuit, IP News, IPWatchdog Articles, Litigation, Patents, anticipation, CAFC, drug patents, intellectual property, Method of Treatment Claims, obviousness, patent, patent infringement, Patent Litigation, Patentability, patentability requirements, product-by-process claims